Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06468397




Registration number
NCT06468397
Ethics application status
Date submitted
27/05/2024
Date registered
21/06/2024

Titles & IDs
Public title
Acute Retinal Detachment Repair With the iSeelr™ Retinal Detachment Repair System
Scientific title
An Improved Retinal Detachment Repair Method: A First-in-human Clinical Trial of the Safety and Performance of the iSeelr™ Retinal Detachment Repair System to Seal Retinal Tears Intraoperatively
Secondary ID [1] 0 0
RTF-CIP-01
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Rhegmatogenous Retinal Detachment - Macula Off 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye
Mental Health 0 0 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - iSeelr™

Experimental: Retinal Thermofusion - Surgical treatment using the iSeelr™ medical device for retinal detachment repair


Treatment: Devices: iSeelr™
The iSeelr™ device will be used to deliver 1940nm laser output along with low airflow to seal a retinal tear
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Number of participants with successful retinal reattachment without the need for gas tamponade
Timepoint [1] 0 0
Assessment will take place before discharge on day of surgery and on days 1 and 2 post treatment
Primary outcome [2] 0 0
Assessment of intra-operative and post-operative adverse events
Timepoint [2] 0 0
Up to 90 days post treatment

Eligibility
Key inclusion criteria
* Aged 50 years or older.
* Willing and able to comply with all study requirements and visits.
* Provided written informed consent.

Study Eye:

* Recent onset as (demonstrated by symptoms or diagnosis) macular involving rhegmatogenous retinal detachment.
* Detachment due to single or multiple retinal tears in the superior 4 clock hours
* Pseudophakia

Fellow eye:

• Best Corrected Visual acuity (BCVA) of 6/12 or better.
Minimum age
50 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* History of medical, surgical, or other conditions that, in the opinion of the investigator, would limit study participation e.g. unstable diabetes, poorly controlled hypertension.
* Travel limitations that could prevent review at proscribed study intervals or any other time during the study.
* Inability to provide informed consent.
* Anaesthetic risk factors or inability to lie supine for 1 hour.
* Pregnant and/or breast feeding (to be confirmed on treatment day)
* Current systemic infection
* Current ocular infection

Exclusion criteria in the study eye:

* Significant vitreous haemorrhage partially or fully obscuring detailed examination of the retina
* Intraoperative identification of tears beyond the superior 4 clock hours not identified at the screening visit or during pre-operative examination
* Clinical signs of PVR (+1 flare, vitreous clumps, pigment clusters on the inferior retina, rolled retinal tear edge, star-fold)
* Phakic
* Myopia greater than 3 D spherical equivalent as confirmed by last refraction prior to becoming pseudophakic, and/or
* History of glaucoma or elevated intraocular pressure >21
* Prior or current intraocular infection Unable to return for post-treatment visits
* Known inability to attend the emergency department in the event of an adverse event.

Exclusion criteria in the fellow eye:

* Best corrected Visual Acuity (BCVA) worse than 6/12
* Axial length greater than 26mm
* Any potential sight threatening pathology in the fellow eye as determined by the investigator.
* Extensive lattice degeneration,
* Unilateral high myopia as determined by the investigator,
* family history of retinal detachment,
* collagen disorders such as Marfan's or Sticklers syndrome.
* History of ocular trauma
* Evidence of any abnormality of the eye structure as determined by the investigator
* Planned surgery during the study period

Study design
Purpose of the study
Treatment
Allocation to intervention
Not applicable
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
31/07/2024
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/06/2025
Actual
Sample size
Target
10
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
The Royal Victorian Eye and Ear Hospital (RVEEH) - East Melbourne
Recruitment postcode(s) [1] 0 0
3002 - East Melbourne

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Photofuse Pty Ltd
Address
Country
Other collaborator category [1] 0 0
Government body
Name [1] 0 0
United States Department of Defense
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Penelope Allen, FRANZO
Address 0 0
The Royal Victorian Eye and Ear Hospital (RVEEH)
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Peter Keller
Address 0 0
Country 0 0
Phone 0 0
+61 3 9929 8348
Fax 0 0
Email 0 0
peter.keller@eyeandear.org.au
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Data will be analyzed as a complete dataset in the Clinical Study Report


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT06468397